Moderna Stock Dropping Today
Moderna, Inc. (MRNA) shares decreased today after mixed Q1 results: revenue and commercial execution beat expectations but a large onetime litigation charge produced a wider GAAP loss. Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and BioNTech announced positive topline results for their updated 2025-2026...
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an... Moderna Inc (NASDAQ: MRNA) stock is trading sharply lower on Monday afternoon as recent clinical setbacks overshadowed positive pipeline news. MRNA stock is struggling to find support.
Check... Moderna Inc. (MRNA, Financial) shares experienced a significant decline today, with the stock dropping by 21.86%.
This decline was largely in response to the company's recent update on its future performance expectations. Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
These vaccines use a copy of a ... Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and a recent clinical setback overshadowed an announcement about a new, early-stage study. Deliver the greatest possible impact to people through mRNA medicines. A high-level overview of Moderna, Inc.
(MRNA) stock. View (MRNA) real-time stock price, chart, news, analysis, analyst reviews and more.
